A recent study has found that lenacapavir, an injectable medication administered twice a year, is more effective at preventing HIV among gay, bisexual, and transgender people than a daily regimen of Truvada, taken orally, as a form of pre-exposure prophylaxis. The study examined cisgender men, transgender men and women, and nonbinary individuals who have sex … Continue reading Injectable PrEP Better Than Daily Pills, Study Finds